Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-19, Stock:LLY, The news for the past five days is as follows:
2018-10-12: NEWS1: A Financial Overview of Bausch Health in October.NEWS2: How Analysts View Bausch Health in October.NEWS3: 3 Large-Cap Pharma Stocks Performing Better Than Industry.NEWS4: 3 Large-Cap Pharma Stocks Performing Better Than Industry.NEWS5: Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal.NEWS6: Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal.NEWS7: This is Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS8: This is Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS9: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS10: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS11: 3 Large-Cap Pharma Stocks Performing Better Than Industry.NEWS12: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS13: This is Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS14: Lilly and Metastatic Breast Cancer Advocates Launch Thriver Movement to Elevate Understanding of the Daily Impact of the Disease, Encourage Public to do More for MBC.
2018-10-15: NEWS1: Daily Dividend Report: LLY, NEE, SO, VMC, LNT.NEWS2: Daily Dividend Report: LLY, NEE, SO, VMC, LNT.NEWS3: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS4: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS5: What’s Expected for Merck’s Q3 2018 Earnings.NEWS6: Lilly Declares Fourth-Quarter 2018 Dividend.NEWS7: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS8: Eli Lilly’s IPO of Animal Health Company Is Getting ‘Ahead of Itself,’ Goldman Says.NEWS9: Drugmakers will soon talk about price in ads — but not as explicitly as Trump administration wants.NEWS10: Novartis’ Estimates and Recommendations on October 12.NEWS11: Novartis: What to Expect from Q3 Earnings on October 18.NEWS12: New Data Showcasing Lilly's Growing Commitment in Rheumatology to be Featured at the ACR/ARHP Annual Meeting.
2018-10-16: NEWS1: AstraZeneca's (AZN) Lynparza Gets Another Orphan Drug Status.NEWS2: AstraZeneca's (AZN) Lynparza Gets Another Orphan Drug Status.NEWS3: Minnesota accuses insulin makers of deceptive drug pricing.NEWS4: AstraZeneca&apos;s (AZN) Lynparza Gets Another Orphan Drug Status.NEWS5: Minnesota accuses insulin makers of deceptive drug pricing.NEWS6: How Nektar Therapeutics Is Positioned In October.NEWS7: Karen Walker Elected to Lilly Board of Directors.
2018-10-17: NEWS1: Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS.NEWS2: Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS.NEWS3: Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva.NEWS4: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva.NEWS5: Stocks - Netflix Soars in Pre-market; IBM, Tilray, Canopy Growth Sink; Tesla Rises.NEWS6: Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off.NEWS7: Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off.NEWS8: 5 Blue Chip Drug Stocks Poised for Long-Term Gains.
2018-10-18: NEWS1: Pfizer’s Growth Rate and Estimates.NEWS2: Puma Biotech (PBYI) Rides High on Robust Nerlynx Performance.NEWS3: Puma Biotech (PBYI) Rides High on Robust Nerlynx Performance.NEWS4: Better Buy: GlaxoSmithKline plc vs. Eli Lilly.NEWS5: Better Buy: GlaxoSmithKline plc vs. Eli Lilly.NEWS6: Pfizer’s Market Cap and Shareholding Pattern.NEWS7: Better Buy: GlaxoSmithKline plc vs. Eli Lilly.NEWS8: Novo Nordisk (NVO) Faces Pricing Pressure and Competition.NEWS9: Novo Nordisk (NVO) Faces Pricing Pressure and Competition.NEWS10: See what the IHS Markit Score report has to say about Eli Lilly And Co..

Answer: Decrease